This episode we speak to Philip Hemme, the founder and CEO of Labiotech, the leading media organisation covering European biotech. We talk about their rapid growth as a startup, the current state of biotech media, their internationally diverse team, and the benefits of 'open science' to biotech startups.
This episode we chatted to Erin Kim the Communications Director at New Harvest, a non-profit research institute focussed on making cellular agriculture a reality. We talk about the the current state of lab grown meat, the importance of effective science communication in a field prone to hype or hysteria, and the community New Harvest are building through their events.
This episode features our pals Ali Afshar and Ignacio Willats founders of Hackscience, a startup focussed on streamlining research by taking time consuming lab tasks out of hands of the scientists through automation.
This episode features Winfried Hensinger, Professor of Quantum Technologies at the University of Sussex. Following on from our chat with the brilliant Chad Rigetti, we were keen to get the academic perspective on the burgeoning field of quantum computing. We were immediately struck by Winfried's fire for this field, describing it as making science fiction a reality (he made his way into physics via a love of Star Trek).
This episode we chatted to Bethan Wolfenden, the co-founder of Bento Bioworks, a biotech startup that has created a 'laptop size laboratory'. This kit allows the user to perform simple DNA analysis and dramatically reduces the cost of the components you'd need to analyse samples, thus lowering the barrier to entry for molecular biology.
In this episode Tim O'Reilly (CEO of O'Reilly Media) joins us in a far reaching conversation spanning the whole science ecosystem. From the communication of science, to liberating knowledge generated by research from the confines of the static PDF, to the mutual learning experience of colliding technologists and academics,
This episode we speak to Elizabeth Iorns who is the Founder and CEO of Science Exchange. We wanted to get Elizabeth's view on what it really takes change the status quo in science - both from a process perspective in the way we conduct ourselves in a lab with regards to suppliers, but also from an activation standpoint - instead of training people up on reproducibility, actually going out and making change using the resources she had access to.
We speak to Chad Rigetti, CEO of quantum computing startup Rigetti Computing. We dive deep into the challenges that face deep tech startups, the core debates within quantum computing, and what it's like to compete with the likes of Google in this brave new world of the future computer.
This episode we spoke to Imogen Bunyard, CoFounder of Qadre a startup focussed on building blockchain solutions that tackle trust issues within enterprises. This could include tackling the counterfeit drug market. Imogen has a particular knack for breaking down a complex topic (in this case the blockchain), grounding it reality, and imagining use cases that can really make a difference.
This episode was recorded in the bowels of Sussex University when we met up with Tom Baden a Neuroscientist interested in how the visual system processes information. Our motivation for chatting to Tom was a brilliant project called the FlyPi that he developed, along with Andre Chagas another Neuroscientist who joined us via the magic of Skype.
This episode we speak to Zach Mueller, an Amazon Data Scientist and co-Founder of Sound.Bio, Seattle's first DIY Biohackspace. We wanted to hear about how they aim to build a community around biology, the challenges of setting up the lab, and the efforts they go to to educate Seattleites in modern biotech.
In this episode we spoke to Jackie Hunter, CEO of Benevolent Bio, a company that utilises machine learning and AI to find previously overlooked drug candidates within the research literature. Jackie was previously Chief Executive of the BBSRC and comes into the AI space with a wealth of experience in industrial drug discovery.
This week we spoke to Josh Ghaim, CTO of Johnson & Johnson. We were interested in how at around 130 years old, one of the largest organisations on the planet can stay nimble, forward facing, and seek out innovation in new places.
This week we spoke to Katie Rae, the CEO of The Engine, a Cambridge (Mass.) based deep tech accelerator that provides the physical workspace to develop the companies, the Cambridge brain trust to guide the founders, and the financial backing to make each transformative idea a reality. The companies range from robotics, energy, medical devices, and biotech. Prior to The Engine, Katie was the served as Chairman and Managing Director of Boston TechStars.
Our latest episode is with Tom Zeller Jr the Editor in Chief of Undark (formerly at the New York Times). Undark was set up as way of applying hard hitting investigative journalism to the intersection of science and society. Supported by the Knight Foundation, Undark is unbeholden to advertisers which allows them to tackle the cases they want to.